Thyrotropin-secreting pituitary adenomas: Diagnosis and management of patients from one Chinese center

Wiener Klinische Wochenschrift

Volumn 124, Issue 19-20, 2012, Pages 678-684

  Zhao, Weiwei ^a   Ye, Hongying ^a   Li, Yiming ^a   Zhou, Linuo ^a   Lu, Bin ^a   Zhang, Shuo ^a   Wen, Jie ^a   Li, Shiqi ^a   Yang, Yehong ^a   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adenomectomy; Hyperthyroidism; Somatostatin analogs; Thyrotropin secreting pituitary adenoma(TSHoma)

Indexed keywords

ANGIOPEPTIN; IODINE; OCTREOTIDE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ERROR; ENDOCRINE SURGERY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RECORD REVIEW; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROTROPIN SECRETING ADENOMA; TREATMENT OUTCOME;

ADENOMA; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHYSECTOMY; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RADIOTHERAPY, CONFORMAL; THYROTROPIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871621236     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-012-0216-z     Document Type: Article

References (16)

1. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 1996;81:3084-90.
2. DeLellis RA, Lloyd RV, Heitz PU, et al. Tumours of the pituitary. In: DeLellis RA, Lloyd RV, Heitz PU, et al. editors. World Health Organization classification of tumours: Pathology and genetics-tumours of endocrine organs. Lyon: IARC; 2004. pp. 9-39.
3. Beck-Peccoz P, Persani L, Mannavola D, Campi I. Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab. 2009;23:597-606.
4. Beck-Peccoz P, Persani L. TSH-producing adenomas. In: DeGroot LJ, Jameson JL editors. Endocrinology, 5th ed. Philadelphia: Elsevier Saundres; 2006. pp. 475-84.
5. Beck-Peccoz P, Persani L. Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 2002;5:83-88.
6. Laws ER, Vance ML, Jane Jr JA. TSH adenomas. Pituitary 2006;9:313-15.
7. Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, et al. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol. 2005;62:176-81.
8. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev. 1996;17:610-38.
9. Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, et al. The changing spectrum of TSH-secreting pituitary adenomas: Diagnosis and management in 43 patients. Eur J Endocrinol. 2003;148:433-42.
10. Sanno N, Teramoto A, Osamura RY. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg. 2000;93:194-200.
11. Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma. J Formos Med Assoc. 2003;102:164-71.
12. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD. Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab. 1999;84:476-86.
13. Weiss RE, Refetoff S. Resistance to thyroid hormone: Rev Endocr Metab Disord. 2000;1:97-108.
14. Elston MS, Conaglen JV. Clinical and biochemical characteristics of patients with thyroid-stimulating hormonesecreting pituitary adenomas from one New Zealand centre. Intern Med J. 2010;40:214-19.
15. Zielinski G, Podgorski JK, Warczynska A, Koziarski A, Zgliczynski W. Thyrotropin-TSH secreting pituitary tumor. Przegl Lek. 2002;59:1018-23 (Abstract).
16. Yoshihara A, Isozaki O, Hizuka N, Nozoe Y, Harada C, Ono M, et al. Expression of type 5 somatostatin receptor in TSHsecreting pituitary adenomas: A possible marker for predicting long term response to octreotide therapy. Endocr J. 2007;54:133-38.